反应详情

The title compound was prepared as described in Example 1 using 2-amino-5-[2-fluoro-4-(1-hydroxy-1-methylethyl)phenyl]thiophene-3-carboxamide (26 mg, 0.09 mmol) and 4-[(4-chloropyrimidin-2-yl)methyl]-3-(fluoromethyl)morpholine (21.70 mg, 0.09 mmol) as starting materials.